VIR

Healthcare

Vir Biotechnology, Inc.

$9.16-0.32 (-3.32%)

Prev Close

$9.48

Open

$9.61

High

$9.73

Low

$9.12

Volume

1.98M

Market Cap

$1.37B

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Vir Biotechnology, Inc. (VIR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 12 insider sales totaling $1.49M. The most recent insider transaction was by SATO VICKI L (director), who sold $209.2K worth of shares on Mar 3, 2026. Vir Biotechnology, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.37B.

Buys (12M)

$0.00

Sells (12M)

$1.49M

Net Activity

Net Seller

$1.49M

Active Insiders

last 12 mo

VIR Price Chart

VIR Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 3, 2026↗	SATO VICKI L	director	Sell	22,000	$9.51	$209.2K	1,122,590
Feb 26, 2026↗	De Backer Marianne	director, officer: Chief Executive Officer	Sell	14,762	$9.53	$140.7K	1,020,700
Feb 26, 2026↗	Eisner Mark	officer: EVP and Chief Medical Officer	Sell	3,505	$9.69	$34.0K	155,913
Feb 26, 2026↗	SATO VICKI L	director	Sell	42,377	$9.75	$413.4K	1,144,590
Feb 24, 2026↗	De Backer Marianne	director, officer: Chief Executive Officer	Sell	38,078	$7.45	$283.8K	1,035,470
Feb 24, 2026↗	de Verneuil Vanina	General Counsel	Sell	4,445	$7.45	$33.1K	129,799
Feb 24, 2026↗	Eisner Mark	VP	Sell	4,178	$7.45	$31.1K	157,529
Feb 24, 2026↗	O'Byrne Jason	CFO	Sell	2,089	$7.45	$15.6K	164,249
Feb 24, 2026↗	Sabatini Brent	Principal Accounting Officer	Sell	1,829	$7.45	$13.6K	71,043
Feb 18, 2026↗	Sabatini Brent	SVP, Chief Accounting Officer	Sell	1,530	$7.79	$11.9K	0
Feb 3, 2026↗	SATO VICKI L	director	Sell	22,000	$7.71	$169.7K	1,144,390
Jan 5, 2026↗	SATO VICKI L	director	Sell	22,000	$5.93	$130.4K	1,166,390

VIR Insider Buying Activity

The following table shows recent insider purchases of Vir Biotechnology, Inc. (VIR) stock reported via SEC Form 4 filings.

No insider buying activity found for VIR in the last 12 months.

VIR Insider Selling Activity

The following table shows recent insider sales of Vir Biotechnology, Inc. (VIR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 3, 2026↗	SATO VICKI L	director	Sell	22,000	$9.51	$209.2K	1,122,590
Feb 26, 2026↗	De Backer Marianne	director, officer: Chief Executive Officer	Sell	14,762	$9.53	$140.7K	1,020,700
Feb 26, 2026↗	Eisner Mark	officer: EVP and Chief Medical Officer	Sell	3,505	$9.69	$34.0K	155,913
Feb 26, 2026↗	SATO VICKI L	director	Sell	42,377	$9.75	$413.4K	1,144,590
Feb 24, 2026↗	De Backer Marianne	director, officer: Chief Executive Officer	Sell	38,078	$7.45	$283.8K	1,035,470
Feb 24, 2026↗	de Verneuil Vanina	General Counsel	Sell	4,445	$7.45	$33.1K	129,799
Feb 24, 2026↗	Eisner Mark	VP	Sell	4,178	$7.45	$31.1K	157,529
Feb 24, 2026↗	O'Byrne Jason	CFO	Sell	2,089	$7.45	$15.6K	164,249
Feb 24, 2026↗	Sabatini Brent	Principal Accounting Officer	Sell	1,829	$7.45	$13.6K	71,043
Feb 18, 2026↗	Sabatini Brent	SVP, Chief Accounting Officer	Sell	1,530	$7.79	$11.9K	0
Feb 3, 2026↗	SATO VICKI L	director	Sell	22,000	$7.71	$169.7K	1,144,390
Jan 5, 2026↗	SATO VICKI L	director	Sell	22,000	$5.93	$130.4K	1,166,390